Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma

Experimental and Molecular Pathology

Volumn 90, Issue 2, 2011, Pages 231-237

  Majsterek, Ireneusz ^a   Malinowska, Katarzyna ^a   Stanczyk, Malgorzata ^a   Kowalski, Michal ^a   Blaszczyk, Jan ^a   Kurowska, Anna K ^b   Kaminska, Anna ^b   Szaflik, Jerzy ^b   Szaflik, Jacek P ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Anti oxidant enzyme; Comet assay; Glaucoma; Oxidative DNA damage

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RIBONUCLEASE III; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DNA STRAND BREAKAGE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PATHOGENESIS; SYMPTOM;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; DNA DAMAGE; FEMALE; GLAUCOMA, OPEN-ANGLE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 79952023806     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.01.001     Document Type: Article

References (66)

1. Kowalski M., Walczak A., Majsterek I. Matrix metalloproteinases (MMPs): modern molecular markers for open-angle glucoma diagnosis and therapy. Postepy Hig. Med. Dosw. 2008, 62:582-592.
2. Nizankowska M.H., Kaczmarek R. Prevalence of glaucoma in the Wroclaw population. The Wroclaw epidemiological study. Ophthalmic Epidemiol. 2005, 12:363-371.
3. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
4. Hasselwander O., Young I.S. Oxidative stress in chronic renal failure. Free Radic. Res. 1998, 29:1-11.
5. Izzoti A., Sacca S.C. The role of oxidative stress in glaucoma. Mutat. Res. 2006, 612:105-114.
6. Izzoti A., Sacca S.C. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med. 2003, 114:638-646.
7. Traverso C.E., Walt J.G., Kelly S.P., Hommer A.H., Bron A.M., Denis P., Nordmann J.P., Renard J.P., Bayer A., Grehn F., Pfeiffer N., Cedrone C., Gandolfi S., Orzalesi N., Nucci C., Rossetti L., Azuara-Blanco A., Bagnis A., Hitchings R., Salmon J.F., Bricola G., Buchholz P.M., Kotak S.V., Katz L.M., Siegartel L.R., Doyle J.J. Direct costs of glaucoma and severity of the disease a multinational long term study of resource utilisation in Europe. Br. J. Ophthalmol. 2005, 89:1245-1249.
8. Sacca S.C., Izzoti A. Oxidative DNA damage in human trabecular meshwork and its correlation with intraocular pressure and visual field in primary open angle glaucoma. Arch. Ophthalmol. 2005, 123:458-463.
9. Ghanem A.A., Arafa L.F., El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr. Eye Res. 2010, 35:295-301.
10. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
11. Klaude M., Eriksson S., Nygren J., Ahnstrom G. The comet assay mechanisms and technical considerations. Mutat. Res. 1996, 363:89-96.
12. Doetsch P.W., Henner W.D., Cunningham R.P., Toney J.H., Helland D.E. A highly conserved endonuclease activity present in Escherichia coli, bovine, and human cells recognizes oxidative DNA damage at sites of pyrimidines. Mol. Cell. Biol. 1987, 7:26-32.
13. Van Kampen E.J., Zijlstra W.G. Standardization of hemoglobinometry II. The hemiglobincyanide method. Clin. Chim. Acta 1961, 6:538-544.
14. Beers R., Sizer T. Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195:133-140.
15. Little C., O'Brian P. Intracellular GSH-peroxidase with a lipid peroxide substrate. Biophys. Res. Commun. 1968, 31:145-150.
16. Misra H.P., Ridovich J. The role superoxide anion in the autooxidation of epinephrine and a simple assay for the superoxide dismutases. J. Biol. Chem. 1972, 247:3170-3175.
17. Kwon Y.H., Fingert J.H., Kuehn M.H., Alward W.L. Primary open-angle glaucoma. N. Engl. J. Med. 2009, 360:1113-1124.
18. Allingham R.R., Wiggs J.L., Hauser E.R., Larocque-Abramson K.R., Santiago-Turla C., Broomer B., Del Bono E.A., Graham F.L., Haines J.L., Pericak-Vance M.A., Hauser M.A. Early adult-onset POAG linked to 15q11-13 using ordered subset analysis. Invest. Ophthalmol. Vis. Sci. 2005, 46:2002-2005.
19. Acott T.S., Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 2008, 86:543-561.
20. Chen P.P. Blindness in patients with treated open-angle glaucoma. Ophthalmology 2003, 110:726-733.
21. Klein B.E., Klein R., Jensen S.C. Open-angle glaucoma and older-onset diabetes, the Beaver Dam Eye Study. Ophthalmology 1994, 101:1173-1177.
22. Mitchell P., Smith W., Chey T., Healey P.R. Open-angle glaucoma and diabetes, the Blue Mountains eye study, Australia. Ophthalmology 1997, 104:712-718.
23. Ritch R. Exfoliation syndrome: beyond glaucoma. Arch. Ophthalmol. 2008, 126:859-861.
24. Carroll J.F., Tyagi S.C. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am. J. Hypertens. 2005, 18:692-698.
25. Mujumdar V.S., Aru G.M., Tyagi S.C. Induction of oxidative stress by homocysteine impairs endothelial function. J. Cell. Biochem. 2001, 82:491-500.
26. Ramakrishnan S., Sulochana K.N., Lakshmi S., Selvi R., Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J. Biochem. Biophys. 2006, 43:275-283.
27. Dielemans I., de Jong P.T., Stolk R., Vingerling J.R., Grobbee D.E., Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. Rotterdam Study Ophthalmol. 1996, 103:1271-1275.
28. Majsterek I., Blasiak J., Hoser G., Slupianek A., Skorski T. ABL-fusion oncoproteins activate multi-pathway of DNA repair role in drug resistance. Biochimie 2004, 86:53-65.
29. Amouroux R., Campalans A., Epe B., Radicella J.P. Oxidative stress triggers the preferential assembly of base excision repair complexes on open chromatin regions. Nucleic Acids Res. 2010, 38(9):2878-2890.
30. Bandaru V., Sunkara S., Wallace S.S., Bond J.P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair 2002, 1:517-529.
31. Amrani E.L., Perello F.B.A., Real J. Oxidative DNA cleavage induced by an iron(III) flavonoid complex synthesis crystal structure and characterization of chlorobis (flavonolato) (methanol) iron(III) complex. J. Inorg. Biochm. 2006, 100:1208-1218.
32. Gorbunova V., Seluanov A., Mao Z., Hine C. Changes in DNA repair during aging. Nucleic Acids Res. 2007, 35:7466-7474.
33. Xu G., Herzig M., Rotrekl V., Walter C.A. Base excision repair, aging and health span. Mech. Ageing Dev. 2008, 129:366-382.
34. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 2000, 20:6920-6926.
35. Wainfan E., Poirier L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 1992, 52:S2071-S2077.
36. Pogribny I.P., et al. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl deficient rats. Cancer Res. 1995, 55:1894-1901.
37. Vine A.K., Stader J., Branham K., Musch D.C., Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005, 112:2076-2080.
38. Pianka P., Almog Y., Man O., Goldstein M., Sela B.A., Lowenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 2000, 107:1588-1592.
39. Roedl J.B., Bleich S., Schlötzer-Schrehardt U., von Ahsen N., Kornhuber J., Naumann GOH G.O.H., Kruse F.E., Junemann A.G.M. Increased homocysteine levels in tear fluid of patients with primary open-angle glaucoma. Ophthalmic Res. 2008, 40:249-256.
40. Bleich S., Jünemann A., von Ahsen N., Lausen B., Ritter K., Beck G., Naumann G.O., Kornhuber J. Homocysteine and risk of open angle glaucoma. J. Neural Transm. 2002, 109:1499-1504.
41. Vessani R.M., Ritch R., Liebmann J.M., Jofe M. Plasma homocysteine is elevated in patients with exfoliative syndrome. Am. J. Ophthalmol. 2003, 136:41-46.
42. Bousse V., Newman N.J., Sternberg P. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am. J. Ophthalmol. 1997, 124:257-260.
43. Cahill M., Karabatzaki M., Meleady R., Refsum H., Ueland P., Shields D., Raised D. Plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br. J. Ophthalmol. 2000, 84:154-157.
44. Lowenstein A., Goldstein M., Winder A., Lazar M., Eldor A. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology 1999, 106:1817-1820.
45. Brown B.A., Marx J.L., Ward T.P., Hollifield R.D., Dick J.S., Brozetti J.J., Howard R.S. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 2002, 109:287-290.
46. Turgut B., Kaya M., Arslan S., Demir T., Güler M., Kaya M.K. Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin. Interv. Aging 2010, 5:133-139.
47. Bjorkman J.A., Sutherland J., Gusttafson D. Superoxide dismutase and catalase do not improve recovery of regional myocardial contractile function when given at the time of reperfusion after reversible regional ischemia in anesthetized dogs. Basie Res. Cardiol. 1991, 86:236-244.
48. Buczyński A., Wachowicz B., Kedziora-Kornatowska K. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993, 100:223-228.
49. Lin T.L., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
50. Truscott R.J.W. Age-related nuclear cataract - oxidation is the key. Exp. Eye Res. 2005, 80:709-725.
51. Faschinger C., Schmut O., Wachswender C., Mossböck G. Glaucoma and oxidative stress. Determination of malondialdehyde-a product of lipid peroxidation. Ophthalmologe 2006, 103:953-959.
52. Tezel G. Oxidative stress in glaucomatous neurodegeneration mechanisms and consequences. Prog. Retin. Eye Res. 2006, 25:490-513.
53. Tezel G., Luo C., Yang X. Accelerated aging in glaucoma immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci. 2007, 48(3):1201-1211.
54. Brennan L.A., Kantorow M. Mitochondrial function and redox control in the aging eye Role of MsrA and other repair systems in cataract and macular degenerations. Exp. Eye Res. 2009, 88:195-203.
55. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Aalomen R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14(2):194-198.
56. Hegde K.R., Varma S.D. Prevention of oxidative stress to the retina by pyruvate. A preliminary report. Ophthalmologica 2008, 222:194-198.
57. Saccà S.C., Pascotto A., Camicione P., Capris P., Izzotti A. Oxidative DNA damage in the human trabecular meshwork clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 2005, 123(4):458-463.
58. Izzotti A., Sacca' S.C., Longobardi M., Cartiglia C. Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma. Investig. Ophthalmol. Vis. Sci. 2009, 50(11):5251-5258. (November).
59. Kishida K., Kodama T., O'Meara P.D., Shichi H. Glutathione depletion and oxidative stress: study with perfused bovine eye. J. Ocul. Pharmacol. 1985, 1:85-99.
60. Vázquez-Quiñones L.E., García-Castiñeiras S. A comparative study of iron-related metabolic parameters in the eye of three animal species. P R Health Sci. J. 2007, 26:373-383.
61. Liu Y., Hong L., Wakamatsu K., Ito S., Adhyaru B.B., Cheng C.Y., Bowers C.R., Simson J.D. Comparisons of the structural and chemical properties of melanosomes isolated from retinal pigment epithelium, iris and choroid of newborn and mature bovine eyes. Photochem. Photobiol. 2005, 81:510-516.
62. Izzotti A., Longobardi M., Cartiglia C., Saccà S.C. Proteome alterations in primary open angle glaucoma aqueous humor. J. Proteome Res. 2010, 9:4831-4838.
63. Szaflik J.P., Rusin P., Zaleska-Zmijewska A., Kowalsk M., Majsterek I., Szaflik J. Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat. Res. 2010, 697(1-2):19-23. Mar 29.
64. Scibor D., Czeczot H. Catalase: structure, properties, function. Postepy Hig. Med. Dosw. 2006, 60:170-180.
65. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diab. Metab. Res. Rev. 2001, 17:189-212.
66. Aslan M., Cort A., Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic. Biol. Med. 2008, 45(4):367-376.